BOTHELL, Wash., July 10, 2012 /PRNewswire/ -- Cardiac Science Corporation, a global leader in external defibrillation, diagnostic devices and monitoring systems, has announced it will provide data from its Quinton® Q-Tel® Rehabilitation Management Systems to the American Association of Cardiovascular and Pulmonary Rehabilitation's (AACVPR) Outpatient Cardiac Rehabilitation Registry.
The web-based registry is the first of its kind in the United States and will provide cardiac rehabilitation professionals with means to track, document and communicate patient outcomes and program performance.
"We are honored to provide data to this national registry and help sponsor AACVPR in this vital effort to help rehabilitation programs obtain useful benchmarking data," said Neal Long, Cardiac Science president and chief executive officer.
"The registry will integrate with other AACVPR strategic initiatives, including program certification and performance measures, to increase program quality and provide data that are currently unavailable regarding the outcomes of cardiac rehabilitation," said Steven Lichtman, AACVPR 2011–2012 President.
When launched, the registry will allow cardiac rehabilitation professionals to track patient outcomes and program performance in accord with evidence-based guidelines. In addition, it will demonstrate the positive impact of cardiac rehabilitation on morbidity, mortality, physical function and quality of life for heart patients in the United States.
About AACVPR The American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR) is a multidisciplinary professional association of health professionals who serve in the field of cardiac and pulmonary rehabilitation. Its membership includes cardiovascular and pulmonary physicians and nurses, exercise physiologists, physical therapists, behavioral scientists, respiratory therapists, dietitians, and nutritionists. Founded in 1985, the nonprofit association is dedicated to reducing morbidity, mortality, and disability from cardiovascular and pulmonary disease and improving the quality of life for patients and their families. Visit www.aacvpr.org to learn more.
About Cardiac Science
Cardiac Science, a wholly owned subsidiary of Opto Circuits (India) Ltd., develops, manufactures, and markets a family of advanced diagnostic and therapeutic cardiology devices and systems, including automated external defibrillators (AED), electrocardiograph devices (ECG/EKG), cardiac stress treadmill and systems, PC-based diagnostic workstations, Holter monitoring systems, hospital defibrillators, vital signs monitors, cardiac rehabilitation telemetry systems, and cardiology data management systems (informatics) that connect with hospital information (HIS), electronic medical record (EMR), and other information systems. The company sells a variety of related products and consumables and provides a portfolio of training, maintenance, and support services. Cardiac Science, the successor to the cardiac businesses that established the trusted Burdick®, HeartCentrix®, Powerheart®, and Quinton® brands, is headquartered in Bothell, Washington. With customers in almost 100 countries worldwide, the company has operations in North America, Europe, and Asia. For information, call 425.402.2000 or visit http://www.cardiacscience.com.
For updates and information on worldwide defibrillation and cardiac monitoring, find us on Facebook at http://facebook.com/cardiacscience, the Cardiac Science blog at http://www.cardiacscience.com/blog, Twitter at http://twitter.com/cardiacscience, and YouTube at http://budurl.com/CSonYT.
For media inquiries, contact:
For investor inquiries, contact:
Access our company logo: http://www.cardiacscience.com/images/main_logo.gif
SOURCE Cardiac Science Corporation